Defendants not only knew or should have known that their GLP-1RAs cause delayed gastric emptying, resulting in risks of gastroparesis, but they may have sought out the delayed gastric emptying effect due to its association with weight loss. A study published in October found that Ozempic triples the risk of the stomach paralysis among users when compared to users of non-injectable weight loss drugs
Several clinical studies also noted pancreatitis as an Ozempic side effect
Specifically, we investigated the potential mediating roles of T2D and obesity in this relationship
A Note on Fragrance Our copper peptide products are fragrance-free - no added fragrance, no essential oils, no masking scents
*Correspondence: Suzie Chen, [email protected] This article was submitted to Skin Cancer, a section of the journal Frontiers in Oncology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers